Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Net Shares Issued and Repurchased (2021 - 2025)

Invivyd's (IVVD) quarterly Net Shares Issued and Repurchased came in at $12.2 million in Q4 2025, down 14.47% on a YoY basis from $14.2 million in Q4 2024, and up 31.67% quarter-over-quarter from $9.2 million in Q1 2025.

Analysis

Invivyd (IVVD) Net Shares Issued and Repurchased (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $12.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 14.47% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (down 14.47% YoY), and the FY2025 full-year result was $12.2 million, down 14.47% from the prior year.
  • Net Shares Issued and Repurchased improved to $12.2 million in Q4 2025 per IVVD's latest filing, from $9.2 million in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $16.2 million in Q4 2021 and bottomed at $3.1 million in Q1 2023.
  • Historically, Net Shares Issued and Repurchased has averaged $9.6 million across 5 years, with a median of $9.9 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased sank 44.48% in 2023, then soared 153.39% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $16.2 million in 2021, then slipped by 22.31% to $12.6 million in 2022, then dropped by 21.88% to $9.9 million in 2023, then jumped by 44.25% to $14.2 million in 2024, then declined by 14.47% to $12.2 million in 2025.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $12.2 million, $9.2 million, and $14.2 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 12.17 Mn
Mar 31, 2025 9.24 Mn
Dec 31, 2024 14.23 Mn
Mar 31, 2024 3.65 Mn
Dec 31, 2023 9.86 Mn
Mar 31, 2023 3.06 Mn
Dec 31, 2022 12.63 Mn
Mar 31, 2022 5.52 Mn
Dec 31, 2021 16.25 Mn